2型糖尿病人群中高尿酸血症与心血管病死亡风险的队列研究

doi:10.3969/j.issn.1006-3110.2021.04.007

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (771 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨2型糖尿病(type 2 diabetes mellitus,T2DM)队列人群中高尿酸血症与心血管病死亡风险的关系。方法研究对象为江苏省常熟市的T2DM队列人群。应用Cox 回归模型分析基线不同尿酸水平T2DM队列人群心血管病死亡的HR值和95%CI。结果 10 246名T2DM队列人群中累积随访59 032.86人年,平均随访6年,随访期间因心血管病死亡260人。调整潜在的混杂因素后,以基线正常尿酸组为参照,高尿酸血症组发生心血管病死亡的HR(95%CI)为1.753(1.299~2.366)。在男性患者、女性患者、年龄≤60岁、年龄＞60岁、无中心性肥胖、血脂正常、血脂异常、高血压组中,与正常尿酸组相比,高尿酸血症组均可使T2DM患者发生心血管病死亡风险增加,差异有统计学意义(HR分别为1.780、1.756、5.583、2.065、1.964、1.705、1.579和1.748,P<0.05)。排除基线时患有心血管疾病和肾病的患者,剩下的8 686名T2DM患者进行敏感性分析。以基线正常尿酸组为参照,高尿酸血症组发生心血管病死亡的HR(95%CI)为1.250(1.043~1.498)。结论高尿酸血症可以独立增加T2DM患者心血管病死亡的风险。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	顾淑君
	张秋伊
	周正元

关键词 ： 2型糖尿病, 高尿酸血症, 心血管病, 死亡风险, 队列研究

Abstract：Objective To explore the relationship of hyperuricemia with the risk of cardiovascular disease mortality in a cohort of patients with type 2 diabetes mellitus (T2DM). Methods All participants were selected from a cohort study of T2DM patients in Changshu City, Jiangsu Province. Multivariate Cox regression models were used to analyze the hazard ratio (HR) and 95% confidence interval (CI) of cardiovascular disease mortality in T2DM patients with different baseline levels of uric acid. Results Among the 10,246 T2DM patients, follow-ups were accumulatively conducted in 59,032.86 person-years. The median of follow-ups was 6 years, and 260 patients died of cardiovascular disease during the follow-ups. After adjusting for potential confounding factors, the hazard ratio (95% confidence interval) of cardiovascular disease mortality in the hyperuricemia group was 1.753 (1.299-2.366) compared with the baseline normal uric acid group. In the groups with male patients, with female patients, aged ≤60 years, aged >60 years, without central obesity, with normal blood lipid, with dyslipidemia and hypertension, compared with the normal uric acid group, the hyperuricemia group increased the risk of death from cardiovascular disease in the T2DM patients, with statistically significant differences (HR=1.780,HR=1.756,HR=5.583,HR=2.065,HR=1.964,HR=1.705,HR=1.579,HR=1.748, all P<0.05). After excluding patients with cardiovascular disease and kidney disease at baseline, the remaining 8,686 patients with T2DM underwent sensitivity analysis. Compared with the baseline normal uric acid group, the HR (95%CI) of cardiovascular mortality in the hyperuricemia group was 1.250 (1.043-1.498). Conclusion Hyperuricemia is independently associated with increased cardiovascular disease mortality risk in patients with T2DM.

Key words： type 2 diabetes mellitus hyperuricemia cardiovascular disease death risk cohort study

收稿日期: 2020-06-29

R587.1

基金资助:江苏省卫生厅医学创新团队科技项目(K201105);常熟市科技计划项目(CS201812,CS201422)

作者简介: 顾淑君(1987-),女,硕士,主管医师,研究方向:疾病预防与控制。

引用本文:

顾淑君, 张秋伊, 周正元. 2型糖尿病人群中高尿酸血症与心血管病死亡风险的队列研究[J]. 实用预防医学, 2021, 28(4): 435-438. GU Shu-jun, ZHANG Qiu-yi, ZHOU Zheng-yuan. Cohort study on hyperuricemia and the risk of cardiovascular disease mortality in patients with type 2 diabetes mellitus. , 2021, 28(4): 435-438.

链接本文:

https://www.syyfyx.com/CN/10.3969/j.issn.1006-3110.2021.04.007 或 https://www.syyfyx.com/CN/Y2021/V28/I4/435

[1] Sheikhbahaei S, Fotouhi A, Hafezi-Nejad N, et al. Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes[J]. Metab Syndr Relat Disord, 2014, 12(2):102-109.
[2] 孙琳, 王桂侠, 郭蔚莹. 高尿酸血症研究进展[J]. 中国老年学杂志, 2017, 37(4):1034-1038.
[3] 隋淼,张弢,杨晓辉,等.老年2型糖尿病患者血尿酸水平与颈动脉硬化病变间的关系研究[J].检验医学与临床,2017,14(3):413-415.
[4] Kushiyama A, Tanaka K, Hara S, et al. Linking uric acid metabolism to diabetic complications[J]. World J Diabetes, 2014, 5(6):787-795.
[5] Zoppini G,Targher G,Negri C,et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients[J]. Diabetes Care, 2009,32(9):1716-1720.
[6] Ong G,Davis WA,Davis TME. Serum uric acid doesn’t predict cardiovascular or all cause mortality in type 2 diabetes: the fremantle diabetes study[J]. Diabetologia, 2010, 53(7):1288-1294.
[7] Panero F,Gruden G,Perotto M,et al. Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study[J]. Atherosclerosis, 2012, 221(1):183-188.
[8] Ilundain-Gonzalez AI,Gimeno-Orna JA,Saenz-Abad D, et al. Impact of uric acid levels on the risk of long-term cardiovascular mortality in patients with type 2 diabetes mellitus[J]. Endocrinol Diabetes Nutr, 2018, 65(6):335-341.
[9] 顾亦斌, 薛雨星, 盛红艳,等. 2013年常熟市2型糖尿病患者的血糖,血脂及血压控制情况及影响因素分析[J]. 实用预防医学, 2019,26(7):836-840.
[10] 中华医学会糖尿病学会. 中国2型糖尿病防治指南(2010年版)[J].中国实用农村医生杂志,2012,19(4):1-15.
[11] 高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识[J]. 中华内科杂志, 2017,56(3):235-248.
[12] 中华人民共和国卫生部疾病控制司. 中国成人超重和肥胖症预防控制指南[M]. 北京:人民卫生出版社,2006:1-20.
[13] 中国高血压防治指南修订委员会,高血压联盟(中国), 中华医学会心血管病学分会,等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019,24(1):24-56.
[14] 中国成人血脂异常防治指南制订联合委员会,中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419.
[15] 潘晓群, 张永青, 苏健,等. 江苏省2型糖尿病患者遵医行为及影响因素分析[J]. 中国慢性病预防与控制,2019,27(8):585-588.
[16] Spiga R, Marini MA, Mancuso E, et al. Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-κB signaling pathway in HepG2 cells [J]. Arterioscler Thromb Vasc Biol, 2017,37(6):1241-1249.
[17] Kanellis J,Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease[J]. Semin Nephrol, 2005,25(1):39-42.
[18] 蔡晓凌,陈祎霏,韩斐斐,等.高尿酸血症与2型糖尿病[J].中国心血管杂志,2016,21(1):8-10.